跳至主要内容
临床试验/NCT02757495
NCT02757495已完成4 期

Can Caudal Dexmedetomidine Prevents Sevoflurane Induced Emergence Agitation in Children

Suez Canal University1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2016年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
48
试验地点
1
主要终点
Degree of Emergence Agitation will be evaluated-initial

研究概览

简要总结

Emergence agitation (EA) is common phenomenon in pediatric patients undergoing general anesthesia by inhalation agents. The incidence of EA was reported to range from 18% to 80%. Sevoflurane now is the inhalational anesthetic agent of choice for pediatrics, Different strategies have been suggested to decrease the incidence and severity of EA. No gold standard technique for treating EA after sevoflurane anesthesia is currently available. The main question is can caudal dexmedetomidine be used for this purpose?

详细描述

The purpose of this prospective comparative randomized clinical study will be to compare the effects of caudal dexmedetomidine on EA in children undergoing lower abdominal operations under general sevoflurane anesthesia. In addition, characteristics of anesthesia recovery and incidence of adverse effects will be compare. A total of (48) children aged 1-5 years old, The American society of Anesthesiologists (ASA) physical status classification system between I-II of both sex who will be enrolled from April 2016 to April 2017 undergoing for lower abdominal surgeries will be included in the study. Patients will be randomized by computer-generated random numbers in a double blinded fashion to get enrolled into 2 equal groups: Group BD patients (n = 24) will be received single dose caudal epidural analgesia using dexmedetomidine with bupivacaine, whereas Group B patients (n = 24) will be received single dose caudal epidural analgesia with bupivacaine only. The dexmedetomidine used for this study will be prepared in a 1 ml syringe wrapped in aluminum foil by an investigator who will not be involved in the anesthesia process and another 1 ml syringe filled with saline will be prepared too.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 1-5 years old,
  • The American society of Anesthesiologists (ASA) physical status classification system between I-II of both sex who will be enrolled from March 2015 to March 2016 undergoing for lower abdominal surgeries, e.g., hernia and perineal surgeries, e.g., undescended testis and hypospadius will be included in the study.

排除标准

  • mental retardation, developmental delay, known allergy to any of the study drugs, congenital anomalies of spine, neurological or psychiatric illness that may be associated with improper communication, any signs of local infection in the sacrum region, any kind of cardiac conduction disorder, bleeding disorders, any previous cardiovascular disease and parental refusal.

研究组 & 干预措施

Caudal dexmedetomidine

Experimental

In this arm, single dose caudal epidural injection will be done patients in this arm will be given dexmedetomidine (precedex 100 µg/mL parenteral preparation (Hospira ® ) 2 µg/kg in 1 ml/kg bupivacaine 0.25%

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Degree of Emergence Agitation will be evaluated-initial

时间窗: upon awakening

using the pediatric anesthesia emergence delirium scale (PAED), Patients will be considered agitated if they had a score of 16/20 or higher

次要结局

  • Incidence of emergence agitation at different time interval after surgery(10 min ,20 min , 30 min and 60 min after surgery)
  • Emergence time(immediately postoperative)
  • Postoperative pain will be assessed, pain score will be observed and recorded at different time interval after surgery(immediately postoperative and every 4 hours in the first 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ghada A.Kamhawy

lecturer of anesthesia,faculty of medicine, suez canal university

Suez Canal University

研究点 (1)

Loading locations...

相似试验

Can Caudal Dexmedetomidine Prevents Sevoflurane... | 临床试验